CIK 0001447362 · Accelerated filer
CASTLE BIOSCIENCES INC
Sign in to watch- Ticker
- CSTL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770701774
- Phone
- 866-788-9007
- Business address
- 1500 W. PARKWOOD AVE., SUITE 400, FRIENDSWOOD, TX, 77546
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,765,795
- in 18 filings, $4.9M under 10b5-1 plans
Net −$5,765,795. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-28 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −21 | $33.88 | $711 | 11,256 |
| 2026-08-28 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise · Stock option (right to buy) 10b5-1 | −12,428 | 25,329 | ||
| 2026-08-25 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −9,050 | $35.04 | $317K | 66,914 |
| 2026-08-25 | Oelschlager Kristen M Chief Operating Officer | Sale | −7,161 | $34.26 | $245K | 77,872 |
| 2026-08-25 | Oelschlager Kristen M Chief Operating Officer | Sale | −5,223 | $34.64 | $181K | 72,649 |
| 2026-08-24 | Oelschlager Kristen M Chief Operating Officer | Sale | −12,218 | $33.69 | $412K | 85,033 |
| 2026-08-17 | Juvenal Tobin W Chief Commercial Officer | Sale 10b5-1 | −1,730 | $29.59 | $51K | 75,964 |
| 2026-08-14 | Stokes Frank Chief Financial Officer | Sale | −24,908 | $29.77 | $742K | 35,177 |
| 2026-08-14 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise 10b5-1 | +1,100 | $2.39 | $3K | 22,579 |
| 2026-08-14 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −1,100 | $30.02 | $33K | 21,479 |
| 2026-08-14 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,714 | $30.02 | $81K | 20,355 |
| 2026-08-14 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,306 | $30.02 | $69K | 17,301 |
| 2026-08-14 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −278 | $30.02 | $8K | 11,534 |
| 2026-08-14 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −278 | $30.02 | $8K | 11,534 |
| 2026-08-14 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −278 | $30.02 | $8K | 11,534 |
| 2026-08-14 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −278 | $30.02 | $8K | 11,534 |
| 2026-08-14 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise · Stock option (right to buy) 10b5-1 | −1,100 | 37,757 | ||
| 2026-08-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Option exercise 10b5-1 | +2,546 | $2.39 | $6K | 24,025 |
| 2026-08-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −2,546 | $30.68 | $78K | 21,479 |
| 2026-08-05 | MAETZOLD DEREK J Pres. & Chief Exec. Officer | Sale 10b5-1 | −556 | $30.68 | $17K | 23,069 |
Page 4 of 45 · 897 trades